The age of targeted cancer therapies brings the potential for more treatment options, greater effectiveness and fewer side ...

Cancer is a disease of the genome, according to Dr. Elli Papaemmanuil, computational oncologist at MSK. By looking at the ...

to identify new therapeutic targets. A clinical trial that added an immunotherapy drug to standard of care treatment regimens has shown increased survival rates for head and neck cancer patients with ...

Recent results raise hope of new "broad, pan-tumor platform" like Keytruda. The emerging drugs are bispecific antibodies that ...

B-cell lymphoma, particularly diffuse large B-cell lymphoma (DLBCL), is a type of cancer that originates ... making it a promising target for therapeutic intervention. Recent studies have made ...

Vertex and the UK’s genome analysis firm Genomics plc have announced a three-year collaboration to use human genetics and machine learning to improve discovery of targets for precision drugs.

Scientists from A*STAR Genome Institute of Singapore (A*STAR GIS) have uncovered that a key enzyme—P4HA1 prolyl hydroxylase, ...

Scientists from A*STAR Genome Institute of Singapore (A*STAR GIS) have uncovered that a key enzyme – P4HA1 prolyl hydroxylase ...

Proteolytic enzymes are integral to various cellular functions, including extracellular matrix (ECM) remodeling, digestion, and immune modulation. These ...

In this third-generation delivery strain, Raman figured out a way to control when the bacteria, after it has been intravenously injected, invades the cancer cells and delivers the therapy. This ...

IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC Holdings” or the “Company”) has launched Ignite Proteomics LLC (“Ignite”), its new ...